Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Dec 15, 2021

32601_dirs_2021-12-14_243ba86a-6d2f-4a28-83df-4afe43b7f1f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-12-10

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-10 Common Stock M 5363 Acquired 231790 Direct
2021-12-10 Common Stock F 2111 $40.52 Disposed 229679 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-10 Stock option (right to buy) $40.52 A 106376 Acquired 2031-12-09 Common Stock (106376.0) Direct
2021-12-10 Restricted Stock Units $ A 61698 Acquired Common Stock (61698.0) Direct
2021-12-10 Restricted Stock Units $ M 5363 Disposed Common Stock (5363.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 150567 Indirect
Common Stock 127728 Indirect
Common Stock 137965 Indirect
Common Stock 75000 Indirect

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2: On December 9, 2021, the Reporting Person transferred 75,000 shares of Castle Biosciences, Inc. common stock to the DJM Grantor Retained Annuity Trust No. 3 of which the Reporting Person is trustee and beneficiary.

F3: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

F4: Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.

F5: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

F6: 25% of shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.

F7: The RSUs vest in four equal annual installments beginning on December 10, 2022.

F8: On December 10, 2020, the Reporting Person was granted 21,450 RSUs, which vest in four equal annual installments beginning on December 10, 2021.